GROUP ONE TRADING, L.P. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$107,776
-77.9%
4,011
-70.7%
0.00%
-100.0%
Q2 2023$488,578
+151.2%
13,701
+78.9%
0.00%
+100.0%
Q1 2023$194,513
-87.3%
7,658
-79.7%
0.00%
-75.0%
Q4 2022$1,531,464
+107.8%
37,758
+69.3%
0.00%
+300.0%
Q3 2022$737,000
+19.8%
22,309
+27.7%
0.00%0.0%
Q2 2022$615,000
-30.8%
17,475
-9.6%
0.00%0.0%
Q1 2022$889,000
-82.5%
19,337
-74.8%
0.00%
-75.0%
Q4 2021$5,091,000
+6.8%
76,780
+0.5%
0.00%
-20.0%
Q3 2021$4,768,000
-11.5%
76,380
+17.5%
0.01%
-16.7%
Q2 2021$5,385,000
+20.6%
65,025
-3.5%
0.01%
-14.3%
Q1 2021$4,467,000
+57.6%
67,366
+82.3%
0.01%
+40.0%
Q4 2020$2,835,000
-11.2%
36,950
-50.1%
0.01%
-50.0%
Q3 2020$3,191,000
+206.8%
74,104
+207.9%
0.01%
+100.0%
Q2 2020$1,040,000
-58.1%
24,071
-72.1%
0.01%
-75.0%
Q1 2020$2,484,000
+65.0%
86,349
+264.0%
0.02%
+100.0%
Q4 2019$1,505,000
+180.8%
23,722
+24.8%
0.01%
+150.0%
Q3 2019$536,000
+16.8%
19,015
-24.0%
0.00%
-20.0%
Q1 2019$459,000
-2.5%
25,007
-34.0%
0.01%
+25.0%
Q4 2018$471,000
+344.3%
37,916
+386.5%
0.00%
+300.0%
Q2 2018$106,000
-78.6%
7,793
-88.7%
0.00%
-80.0%
Q1 2018$496,000
+190.1%
68,738
-34.9%
0.01%
+150.0%
Q2 2017$171,000
-16.6%
105,588
-4.8%
0.00%0.0%
Q1 2017$205,000
-6.8%
110,888
-21.8%
0.00%0.0%
Q4 2016$220,000
-50.0%
141,860
+137.1%
0.00%
-60.0%
Q3 2016$440,000
+4788.9%
59,832
+3497.8%
0.01%
Q2 2016$9,0001,6630.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders